Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» retinal vein occlusion
retinal vein occlusion
FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Fri, 10/27/23 - 11:34 am
Vabysmo
Genentech
Roche
retinal vein occlusion
Amid Eylea showdown, Roche's Vabysmo shows durability in retinal vein occlusion
Fierce Pharma
Wed, 10/11/23 - 10:13 am
Roche
retinal vein occlusion
Vabysmo
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Trials cue up new use for Roche's eye disease drug Vabysmo
Pharmaphorum
Fri, 02/10/23 - 10:24 am
Roche
Vabysmo
clinical trials
retinal vein occlusion
Allergan’s intravitreal implant wins approval in China
Drug Delivery Business News
Mon, 10/30/17 - 09:54 am
Allergan
China
intravitreal implants
devices
Ozurdex
retinal vein occlusion
Bayer nabs new Eylea nod to help it toward 2015 sales target
Fierce Pharma
Fri, 02/27/15 - 06:59 pm
Bayer
Europe
Eylea
retinal vein occlusion
Lucentis improves sight after 7 days in 2 studies
Reuters
Mon, 10/5/09 - 10:49 am
Lucentis
Genentech
RVO
retinal vein occlusion
Roche